GATA $60M IN CUSTOMER ORDERZZZ NEWZZZ!!!MASSIVE RE
Post# of 145147
Posted On: 03/11/2014 9:21:59 AM
GATA >>$60M IN CUSTOMER ORDERZZZ NEWZZZ!!!MASSIVE REVZZZ CONTINUE PLAYAZZZ
Groupe Athena, Inc. Provides Guidance on Current Orders
Mar 11, 2014
OTC Disclosure & News Service
Mumbai, MHT, India -
Groupe Athena, Inc.(Pink Sheets: GATA) made the following announcement:
The guidance contained below represents forecasts,which indicate possible outcomes and are provided to assist investors withthe development of earnings estimates. While Groupe Athena, Inc. believes thatthese forecasts represent the best estimate of management as to future events,actual events may differ from these forecasts, and such differences could bematerial. These forecasts are subject to risks identified under "SafeHarbor Statement" below.
Groupe Athena, Inc.announced today they have approximately $60 million incustomer orders that they are currently processing, and they are hopeful thatthis number will increase in the near term. Based on the orders in handthe company expects to be able to convert at least one half or approximately $30 million intorevenue during the current fiscal year ending June 30, 2014. This would puttotal current year revenue projections at $65,000,000, in line with projectionsand provide a solid revenue base to build on for the 2015 fiscal period.
As was previouslystated, the Indian pharmaceutical industry is increasingly focusing on exportsto the United States andGATA is well positioned to help them get their products approved by the FDA forsales in the US. The Company believes it has an advantageover competitors due to the facilities based in India,and their ability to deliver quick feedback to clients that could result inexpedited order generation. With recent additions to equipment, the companywill continue to take on additional contracts and continue to anticipatefurther growth.
AboutGroupe Athena, Inc.
Groupe Athena, Inc. was incorporated in June 2008 andbegan operations on July1 ofthat year. The company is a research and testing organization and helps variouspharmaceutical and medical products and devices companies in India and Southeast Asia to get regulatory approvals and facilitate exports oftheir products to the United States.The Company accomplishes this by assisting clients from concept throughdevelopment, providing consultation on regulatory requirements, filings andprocesses.
Thecompany has a research and marketing facility in India thatcurrently employs 19 consultants and marketing personnel and is working towardsaggressively expanding its presence in the Indian pharmaceutical industry. TheCompany's web address is www.groupeathena.com.
For more information contact:
Paul Cornell
cornellpaul6@gmail.com
Safe Harbor Statement
Certain statements set forth in this press releaseconstitute "forward-looking statements." Forward-looking statementsinclude, without limitation, any statement that may predict, forecast,indicate, or imply future results, performance or achievements, and may containthe words "estimate", "project", "intend","forecast", "anticipate", "plan","planning", "expect", "believe", "willlikely", "should", "could", "would","may" or words or expressions of similar meaning. Such statements arenot guarantees of future performance and are subject to risks and uncertaintiesthat could cause the company's actual results and financial position to differ materially from those includedwithin the forward-looking statements. Forward-looking statements involve risksand uncertainties, including those relating to the Company's ability to grow it's business. Actual results may differ materially from the resultspredicted and reported results should not be considered as an indication offuture performance. The potential risks and uncertainties include, amongothers, the Company's limited operating history, the limited financialresources, domestic or global economic conditions, activities of competitors, the presence of newor additional competition and conditions of equity markets.
SOURCEGroupe Athena, Inc.
Copyright © 2014 OTC Markets. All Rights Reserved
(0)
(0)